UBS Group’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $59.9M | Buy |
|
|||||
|
2025
Q2 | $41.5M | Sell |
|
|||||
|
2025
Q1 | $51.8M | Buy |
|
|||||
|
2024
Q4 | $40.7M | Buy |
|
|||||
|
2024
Q3 | $18.2M | Buy |
|
|||||
|
2024
Q2 | $14.2M | Sell |
|
|||||
|
2024
Q1 | $19.8M | Sell |
|
|||||
|
2023
Q4 | $21.3M | Buy |
|
|||||
|
2023
Q3 | $18.9M | Sell |
|
|||||
|
2023
Q2 | $19.8M | Sell |
|
|||||
|
2023
Q1 | $25.4M | Sell |
|
|||||
|
2022
Q4 | $39M | Buy |
|
|||||
|
2022
Q3 | $21.4M | Buy |
|
|||||
|
2022
Q2 | $24M | Sell |
|
|||||
|
2022
Q1 | $26.3M | Sell |
|
|||||
|
2021
Q4 | $23.3M | Sell |
|
|||||
|
2021
Q3 | $24.3M | Buy |
|
|||||
|
2021
Q2 | $31.5M | Buy |
|
|||||
|
2021
Q1 | $21.7M | Sell |
|
|||||
|
2020
Q4 | $27.7M | Sell |
|
|||||
|
2020
Q3 | $34M | Sell |
|
|||||
|
2020
Q2 | $27.6M | Sell |
|
|||||
|
2020
Q1 | $29.1M | Buy |
|
|||||
|
2019
Q4 | $40.1M | Sell |
|
|||||
|
2019
Q3 | $55.8M | Buy |
|
|||||
|
2019
Q2 | $61.2M | Sell |
|
|||||
|
2019
Q1 | $72.8M | Buy |
|
|||||
|
2018
Q4 | $48.3M | Sell |
|
|||||
|
2018
Q3 | $74.9M | Buy |
|
|||||
|
2018
Q2 | $69.5M | Buy |
|
|||||
|
2018
Q1 | $57.3M | Buy |
|
|||||
|
2017
Q4 | $49.8M | Buy |
|
|||||
|
2017
Q3 | $43.9M | Sell |
|
|||||
|
2017
Q2 | $48.8M | Sell |
|
|||||
|
2017
Q1 | $49.1M | Buy |
|
|||||
|
2016
Q4 | $31.2M | Buy |
|
|||||
|
2016
Q3 | $26.4M | Buy |
|
|||||
|
2016
Q2 | $28.3M | Buy |
|
|||||
|
2016
Q1 | $19.2M | Sell |
|
|||||
|
2015
Q4 | $22.3M | Sell |
|
|||||
|
2015
Q3 | $24.4M | Buy |
|
|||||
|
2015
Q2 | $27.2M | Buy |
|
|||||
|
2015
Q1 | $21.3M | Sell |
|
|||||
|
2014
Q4 | $27.1M | Buy |
|